BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20260514T223809
CREATED:20181022T121303Z
LAST-MODIFIED:20181022T121355Z
UID:18094-1552867200-1553039999@www.pharmajournalist.com
SUMMARY:21st Annual Superbugs & Superdrugs Conference
DESCRIPTION:As the global threat of antimicrobial resistance continues to grow\, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. \n \nSMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London\, UK for its 21st year running\, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities\, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections. \nThe two-day conference will also host a diverse gathering of policy makers and economists\, in addition to big pharmas and biotechs\, who will discuss incentives\, partnerships\, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data\, as well as alternatives to antibiotics\, such as monoclonal antibodies and antimicrobial peptides.  \n2019 HIGHLIGHTS:  \n\nAnalyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR\nHear about novel immune-therapeutics to target Gram-negative bacterial infections\nLearn about strategies to combat β-lactamases\nEvaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship\nExplore the role of plasmids in the evolution of antimicrobial resistance\n\nJoin us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance\, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures\, University of Oxford\, MedImmune\, HPRA\, GARDP\, DNDi\, Bioharmony Therapeutics\, and many more.  \nEarly Bird Discounts!  \nBook by November 30th and save £400\nBook by December 14th and save £200\nBook by January 31st and save £100  \nFor more information and to register online\, please visit http://www.superbugssuperdrugs.com/pjwl
URL:https://www.pharmajournalist.com/event/21st-annual-superbugs-superdrugs-conference/
LOCATION:HOLIDAY INN KENSINGTON FORUM\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:mmandic@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20260514T223809
CREATED:20181029T164425Z
LAST-MODIFIED:20181029T164425Z
UID:18183-1552867200-1553039999@www.pharmajournalist.com
SUMMARY:3rd Annual Drug Discovery Chemistry
DESCRIPTION:SMi’s 3rd Annual Drug Discovery Chemistry  \nDeveloping your R&D pipeline with strategies to deliver small molecules  \nConference: 18 – 19 March 2019\nWorkshop: 20 March 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nWebsite: www.drug-discovery.co.uk/PJwl \nCHAIRED BY: \nRoderick Hubbard\, Senior Fellow\, Vernalis Research Ltd\nDarren Green\, Director of Molecular Design\, GSK \nSMi is proud to present its 3rd Annual Drug Discovery Chemistry event\, taking place on the 18th-19th March 2019. \n \nThe fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market\, however\, demand for novel drugs is still steadily increasing.M \nThis year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines\, with optimization of the R&D process to become cheaper\, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present\, as the process is overall long\, expensive and often potential drugs will fail late in clinical trials\, wasting resources and time. \nThe event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted\, and likewise\, offer new drug targets for existing diseases that could potentially offer better clinical outcomes\, such as within the development of cancer drugs. \nDrug Discovery Chemistry 2019 will look at various developments within the field\, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines\, reduce their R&D cost and timelines\, and ultimately\, increase their medicine output for commercial success. \nEvent Hashtag: #SMiDrugDisChem \nKEY SPEAKERS INCLUDE: \n\nVivek Vishnudas\, Senior Vice President Drug discovery & Platform Sciences\, Berg LLC\nTobias Gabriel\, Global Head of Discovery Chemistry\, Novartis\nGovinda Bhisetti\, Principal Investigator and Head of Computational Chemistry\, Biogen\nHasane Ratni\, Expert Scientist\, F Hoffmann-La Roche\nAlexander Hillisch\, Director of Medicinal Chemistry\, Bayer \n\nKEY TOPICS FOR 2018 INCLUDE: \n\nDiscuss the impact of the use of novel computational techniques on R&D pipelines\nHear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment\nDiscover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process\nExplore the potential of new modalities to transform therapeutics\nLearn about current strategies to increase drug discovery success \n\nPost conference workshop on 20 March 2019 \nArtificial Intelligence in Drug Discovery \nLed by: Nick Camp\, Consultant \nWHO SHOULD ATTEND \nCEOs\, Presidents\, Vice Presidents and Global Heads\, Executive Directors\, Vice President & Global head\, Principal Scientists\, Heads of Business Development\, Directors of Pharma/Biotech firms. \nEARLY BIRD-RATES \n\nBOOK BY 30 NOVEMBER AND SAVE £400\nBOOK BY 15 DECEMBER AND SAVE £200\nBOOK BY 31 JANUARY AND SAVE £100
URL:https://www.pharmajournalist.com/event/3rd-annual-drug-discovery-chemistry/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190321
DTSTAMP:20260514T223809
CREATED:20171108T010017Z
LAST-MODIFIED:20181122T123741Z
UID:3856-1552953600-1553126399@www.pharmajournalist.com
SUMMARY:ProcureCon Pharma 2019
DESCRIPTION:Taking place on 19th-20th March 2019 in Frankfurt\, ProcureCon Pharma is the only Conference for CPOs & Senior Procurement Executives from leading pharma Companies \n \nJoin 150+ senior procurement professionals from Merck\, AstraZeneca\, Roche\, Sanofi\, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions\, speed up transformation and co-create value with business partners. To learn more about ProcureCon Pharma\, download the agenda. \nTake away solutions to all of your top challenges: \n\nMaster analytical and digital procurement in pharma\nBuild strategic partnerships with your internal stakeholders\nDesign and train a high-performing global pharma procurement team\nMove beyond savings with key CROS and CMOS to unlock hidden innovation\n\nFor more information including the incredible speaker line-up\, take a look at the conference brochure here: https://bit.ly/2yIP6a1 \nBook your place online today: https://bit.ly/2PvKzS8 and get 15% off the current ticket price with our exclusive discount code – “PCPPJ15”
URL:https://www.pharmajournalist.com/event/procurecon-pharma-2019/
LOCATION:Steigenberger Frankfurter Hof\, Am Kaiserplatz\, Frankfurt/Main\, 60311\, Germany
ORGANIZER;CN="Worldwide Business Research":MAILTO:Procurecon@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260514T223809
CREATED:20181109T151157Z
LAST-MODIFIED:20181126T130220Z
UID:18365-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:ePharma IMPACT
DESCRIPTION:ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative\, next generation omni-channel strategies. \nThe 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact. \nHow do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships\, and greater influence over impactful marketing strategy. \nThe 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.
URL:https://www.pharmajournalist.com/event/epharma-impact/
LOCATION:NY Hilton 1335 Ave of the Americas New York\, NY 10017\, NY\, United States
ORGANIZER;CN="Knect365":MAILTO:register@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190321
DTSTAMP:20260514T223809
CREATED:20181214T104719Z
LAST-MODIFIED:20181214T104719Z
UID:18830-1552953600-1553126399@www.pharmajournalist.com
SUMMARY:Pharma Security World 2019 - Anti-Counterfeiting\, Drug Serialization and Supply-Chain Security Conference
DESCRIPTION:The Counterfeit medicines are turning into a serious concern around the world\, and have progressively been showing up through the real pharmaceutical supply chain\, including community and online drug stores. What’s more\, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue\, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security World 2019 – Supply-Chain\, Drug Serialization and Anti-Counterfeiting Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/pharma-security-world-2019-anti-counterfeiting-drug-serialization-and-supply-chain-security-conference/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260514T223809
CREATED:20190219T121841Z
LAST-MODIFIED:20190219T121841Z
UID:19638-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:Innate Killer Summit 2019
DESCRIPTION:Accelerate to Market Genetically Engineered\, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications \n The Innate Killer Summit 2019 discusses safer\, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy. \n \nIt will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability. \nBringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.
URL:https://www.pharmajournalist.com/event/innate-killer-summit-2019/
LOCATION:Hilton San Diego Gaslamp Quarter\, 401 K St\, San Diego\, CA 92101
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR